NGM Biopharmaceuticals Funding: $26M Raised, Series A (2015)
NGM Biopharmaceuticals is based in South San Francisco, CA. It has raised $26M in total funding. Latest round: Series A.
NGM Biopharmaceuticals funding overview
NGM Biopharmaceuticals is based in South San Francisco, CA. NGM Biopharmaceuticals has raised $26M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2015. The round record for NGM Biopharmaceuticals runs through 2015; nothing later has been disclosed. Investors on record include TCG, Prospect Venture Partners, Rho Ventures. 3 distinct backers are named across the disclosed rounds.
NGM Biopharmaceuticals at a glance
Total raised
$26M
Latest round
Series A
Latest round date
March 2015
Headquarters
South San Francisco, CA
Notable investors
TCG, Prospect Venture Partners, Rho Ventures
Frequently asked about NGM Biopharmaceuticals funding
How much has NGM Biopharmaceuticals raised?
NGM Biopharmaceuticals has raised $26M in total disclosed funding across the rounds on record.
Who has invested in NGM Biopharmaceuticals?
TCG, Prospect Venture Partners, Rho Ventures are named among the investors backing NGM Biopharmaceuticals.
What was the latest NGM Biopharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in March 2015.
Where is NGM Biopharmaceuticals based?
NGM Biopharmaceuticals is based in South San Francisco, CA.
When did NGM Biopharmaceuticals last raise?
The last disclosed NGM Biopharmaceuticals round closed in March 2015 at Series A.
Every NGM Biopharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in South San Francisco at a similar stage.
